Artificial Saliva Market Growth is Expected
The artificial saliva market growth is expected to project with an exponential CAGR of 13.9% from 2017-2025.
A value of just under US$ 1.5 billion by 2025.
The WHO says, oral diseases are the fourth-most expensive disease to treat across the world. Making its maintenance expenditure a huge healthcare concern. This affects both developed and developing countries. Persistence Market Research finds this a great time to analyze the global artificial saliva market in its report.
‘Artificial Saliva Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’.
Product Type – Oral Sprays Rehydration Preferred Option in Artificial Saliva Market
Oral sprays account for a market share of almost 30% of the artificial saliva market by product type in 2017 and might grow to 31% by end of 2025. Sprays have an attractiveness index of 1.6, surpassing other product types in the artificial saliva market for its affordability and convenience.
Age Group – Pediatric Patients Rarely Turn to the Artificial Saliva Market.
Adult patients dominate the artificial saliva market by age group. Since more adult patients have dry mouth condition than pediatric ones. The adult segment is expected to record a huge CAGR of 14.2% for the period 2017-2025.
Distribution Channel – Compel Retail Pharmacies to Stock up in Artificial Saliva Market.
Retail pharmacies make very effective distribution channels for the artificial saliva market. Patients tend to visit retail pharmacies more than hospital pharmacies or mail-order pharmacies. Having an assessed value of more than US$ 200 million in 2017 alone. Key stakeholders in the artificial saliva market must target this distribution channel.
Region – Spitting Distance between North America and Europe in Artificial Saliva Market
North America and Europe have a similar market share in the artificial saliva market. The former being a bit larger and on track to witness a higher CAGR. The North America artificial saliva expects a push of more than US$ 535 million by the end of 2025. Due to the easy availability of artificial saliva products and having a large consumer base on the continent.
Also linking it with a strong medical foundation.
Persistence Market Research’s report has profiled some of the leading companies actively involved in the artificial saliva market.
Namelt, GlaxoSmithKline plc, Cipla Limited, Mission Pharmacal Company, Fresenius Kabi, Valeant Pharmaceuticals International, Midatech Pharma Plc., Perrigo Company Plc., CCMed Group Entod International, Laboratorios Kin, S.A., ICPA HEALTH PRODUCTS, Mission Pharmacal Company, Biocosmetics Laboratories, and Forward Science.
Important Insights on the Artificial Saliva Market
Companies must focus their attention on brand-building exercises. In fact, the artificial saliva market has a lot of options, and loyalty and trust factors affect the customer’s choice. Thus, companies in the artificial saliva market should take this very seriously for brand development leads to emotional attachment with the end-user.
Plus, increasing both the organizational top and bottom lines requires a strong distribution network.
Promotional activities held in tandem with oncologists, physicians, and retail pharmacies are the perfect opportunity to increase sales in the artificial saliva market. Connecting the demand-supply imbalance can take time in the artificial saliva market. E.g. – Laboratories Kin S.A. has an extremely profitable business in Brazil. This is because of its local pharmacist network and hospitals as faced to its offerings outside the nation.
Article by: Persistence Market Research
Lorin Berland, DDS
Leave a Reply